AC
DCPH

Armistice Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Armistice Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,900,000
Closed -$92.8M – 404
2024
Q1 		$92.8M Buy
5,900,000
+700,000
+13% +$10.8M 1.23% 9
2023
Q4 		$83.9M Buy
5,200,000
+588,000
+13% +$7.5M 1.15% 8
2023
Q3 		$58.7M Buy
4,612,000
+52,000
+1% +$717K 0.9% 20
2023
Q2 		$64.2M Buy
4,560,000
+460,000
+11% +$6.58M 0.93% 22
2023
Q1 		$63.3M Sell
4,100,000
-1,072,000
-21% -$17.9M 0.91% 26
2022
Q4 		$84.8M Buy
5,172,000
+404,000
+8% +$6.57M 1.48% 15
2022
Q3 		$88.2M Sell
4,768,000
-632,000
-12% -$9.92M 1.53% 14
2022
Q2 		$71K Sell
5,400,000
-436,000
-7% -$4.81M 1.24% 20
2022
Q1 		$54.1M Buy
5,836,000
+2,405,846
+70% +$20.5M 1.05% 29
2021
Q4 		$33.5M Buy
3,430,154
+2,752,154
+406% +$51.8M 0.55% 44
2021
Q3 		$23M Buy
678,000
+206,000
+44% +$6.57M 0.39% 65
2021
Q2 		$17.3M Buy
+472,000
New +$18.3M 0.31% 73

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Armistice Capital's DCPH Position: Q2 2024 in Review

Armistice Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 5,900,000 shares — an estimated $92.8M sold.

Armistice Capital first reported a position in DCPH in Q2 2021 and held it in 12 quarters. The position peaked at $92.8M in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Armistice Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Armistice Capital sold 5,900,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $92.8M.
  • Armistice Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Armistice Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $92.8M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.